Literature DB >> 20043018

2009 in reflection.

.   

Abstract

Mesh:

Year:  2010        PMID: 20043018     DOI: 10.1038/nrd3086

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  11 in total

1.  Gearing up for follow-on biologics.

Authors:  Bethan Hughes
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

2.  The comparative effectiveness challenge.

Authors:  Bethan Hughes
Journal:  Nat Rev Drug Discov       Date:  2009-04       Impact factor: 84.694

3.  Novel consortium to address shortfall in innovative medicines for psychiatric disorders.

Authors:  Bethan Hughes
Journal:  Nat Rev Drug Discov       Date:  2009-07       Impact factor: 84.694

4.  Toward biosimilar monoclonal antibodies.

Authors:  Christian K Schneider; Ulrich Kalinke
Journal:  Nat Biotechnol       Date:  2008-09       Impact factor: 54.908

Review 5.  Follow-on biologics: data exclusivity and the balance between innovation and competition.

Authors:  Henry Grabowski
Journal:  Nat Rev Drug Discov       Date:  2008-05-12       Impact factor: 84.694

6.  Defining innovation.

Authors:  Bethan Hughes
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

7.  An audience with...Sir Michael Rawlins.

Authors:  Sir Michael Rawlins
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

Review 8.  Lessons from 60 years of pharmaceutical innovation.

Authors:  Bernard Munos
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

9.  Pharmaceutical industry financial performance.

Authors:  Michael Goodman
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

10.  Market watch: Sales of biologics to show robust growth through to 2013.

Authors:  Michael Goodman
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.